NIH Common Fund Data Ecosystem (CFDE) FAIR Rubric

A rubric for evaluating the FAIRness of NIH-CFDE Resources

Tags: nihcommonfund

URL(s):

View Associations

Rubric Assessments (626384)


Assessment Metrics Date
Target Project   Contact information is provided for the creator(s) of the dataset. Globally unique identifier Machine-readable metadata Standardized metadata Resource identifier in metadata Open, Free, Standardized Access protocol Digital resource license Metadata license NIH program name is available for querying NIH project name is available for querying The institution that created this dataset is available A biological assay is present and resolvable in CFDE-specified ontology (OBI) A relevant anatomical part is present and resolvable in the UBERON Ontology A relevant disease is present and resolvable in the MONDO Ontology A relevant file type is present and resolvable in the EDAM Ontology A relevant taxonomy is present and resolvable in the NCBITaxon Ontology A relevant cell line is present and resolvable in the Cellosaurus Ontology A landing page exists and is accessible
CH5424802 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Basal profile of receptor tyrosine kinase signaling network measured by ELISA LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
iPSC (Exp 1) - ALS, SMA and Control (unaffected) subject-derived iPSC lines- ATAC-seq LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) yes (1.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
PLSR model loadings (pMEK and pERK excluded) from analysis of the covariation of molecular signals with cell viability and apoptosis fraction in BRAF(V600E/D) melanoma cell lines LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
P100 data - Chemical perturbations (MCF10A Common Project) LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA MCF10A Staining Set 1] LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
HG-6-64-01 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
iPSC (Exp 1) - ALS, SMA and Control (unaffected) subject-derived iPSC lines - RNA-seq LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
L1000 gene expression profiling assay - DOS small molecule perturbagens LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
XMD11-50 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
diMN (Exp 3) - ALS and Control (unaffected) diMN cell lines differentiated from iPS cell lines using a short and direct differeintiation protocol - RNA-seq LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
GCP data - Chemical perturbations (MCF10A Common Project) LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) yes (1.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
P100 aggregated data - Chemical perturbations LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA HMEC240L Staining Set C LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
U87 cells -- High-throughput Secretomic Analysis of Single Cells LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
diMN (Exp 3) - ALS and Control (unaffected) diMN cell lines differentiated from iPS cell lines using a short and direct differeintiation protocol - ATAC-seq LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) yes (1.00) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA YAPC Staining Set 1 LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Breast Cancer Profiling Project, Gene Expression 1: Baseline mRNA sequencing on 35 breast cell lines LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA PC3 Staining Set 2 LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
GW-5074 KiNativ -- dose response experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
QL-XII-47 KiNativ -- single dose experiment LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
Breast Cancer Profiling Project - Proteomics 1: 1 total proteome dataset for a 35-cell line breast cancer panel under basal conditions LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
MEMA PC3 Staining Set 1 LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019
P100 aggregated data - CRISPR perturbations LINCS: Assessment of NIH Common Fund Resources with C2M2
maybe (0.50) no (0.00) yes (1.00)   yesbut (0.75) yes (1.00) no (0.00) yes (1.00) no (0.00) yes (1.00) yesbut (0.75) nobut (0.25) no (0.00) no (0.00) nobut (0.25) no (0.00) no (0.00) yes (1.00) Sep 23, 2019